Norman D. Schwartz - 01 Sep 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Issuer symbol
BIO
Transactions as of
01 Sep 2024
Net transactions value
-$1,736,498
Form type
4
Filing time
04 Sep 2024, 20:35:00 UTC
Previous filing
28 Aug 2024
Next filing
10 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +3,005 +0.69% $0.000000 435,925 01 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $542,073 -1,607 -0.37% $337.32 434,318 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +2,081 +0.48% $0.000000 436,399 01 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $270,193 -801 -0.18% $337.32 435,598 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1,266 +0.29% $0.000000 436,864 01 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $183,839 -545 -0.12% $337.32 436,319 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1,805 +0.41% $0.000000 438,124 02 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $325,514 -965 -0.22% $337.32 437,159 02 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +2,320 +0.53% $0.000000 439,479 03 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $414,879 -1,241 -0.28% $334.31 438,238 03 Sep 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 13,006 01 Sep 2024 By Spouse F2
holding BIO BIOB Bio-Rad B Common Stock 4,060,054 01 Sep 2024 By Blue Raven Partners, L.P. F3
holding BIO BIOB Bio-Rad B Common Stock 361,466 01 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -3,005 -25% $0.000000 9,015 01 Sep 2024 Bio-Rad A Common Stock 3,005 $0.000000 Direct F4, F5
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -2,081 -33% $0.000000 4,164 01 Sep 2024 Bio-Rad A Common Stock 2,081 $0.000000 Direct F4, F6
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1,266 -50% $0.000000 1,266 01 Sep 2024 Bio-Rad A Common Stock 1,266 $0.000000 Direct F4, F7
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1,805 -100% $0.000000 0 02 Sep 2024 Bio-Rad A Common Stock 1,805 $0.000000 Direct F4, F8
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -2,320 -100% $0.000000 0 03 Sep 2024 Bio-Rad A Common Stock 2,320 $0.000000 Direct F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F8 On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F9 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.